HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

L Jeffrey Medeiros Selected Research

T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)

2/2008The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
8/2004Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


L Jeffrey Medeiros Research Topics

Disease

102Neoplasms (Cancer)
12/2015 - 02/2002
55Lymphoma (Lymphomas)
11/2015 - 02/2002
41Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2015 - 05/2002
24Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
12/2015 - 06/2002
24Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2015 - 02/2004
24Hodgkin Disease (Hodgkin's Disease)
03/2014 - 02/2002
22Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2013 - 05/2002
15B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2013 - 05/2002
14B-Cell Lymphoma (Lymphoma, B Cell)
05/2015 - 11/2002
13Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2015 - 04/2002
13Chromosome Aberrations (Chromosome Abnormalities)
01/2015 - 04/2006
10Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2015 - 11/2002
10Leukemia
01/2015 - 02/2004
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2014 - 11/2002
9T-Cell Lymphoma (Lymphoma, T Cell)
05/2015 - 09/2002
9Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2011 - 05/2002
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2015 - 01/2009
6Genetic Translocation (Chromosomal Translocation)
12/2014 - 04/2002
6Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2011 - 11/2002
6Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2011 - 11/2002
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2015 - 05/2002
5Plasmacytoma
08/2015 - 11/2002
5Multiple Myeloma
07/2013 - 07/2008
5Mycosis Fungoides
02/2010 - 09/2002
4Residual Neoplasm
08/2014 - 02/2002
4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2014 - 02/2002
4Carcinoma (Carcinomatosis)
08/2013 - 06/2005
4Lymphomatoid Papulosis
07/2012 - 08/2004
4Burkitt Lymphoma (Burkitt's Lymphoma)
08/2011 - 11/2002
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2009 - 05/2002
3Fibrosis (Cirrhosis)
10/2015 - 07/2004
3Acute Promyelocytic Leukemia
01/2015 - 03/2004
3Primary Myelofibrosis (Myelosclerosis)
05/2014 - 07/2004
3Paraproteinemias (Monoclonal Gammopathy)
09/2012 - 02/2005

Drug/Important Bio-Agent (IBA)

31anaplastic lymphoma kinaseIBA
11/2014 - 09/2002
25rituximab (Mabthera)FDA Link
12/2015 - 02/2002
15Proteins (Proteins, Gene)IBA
12/2010 - 02/2002
13Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015 - 03/2002
13Cyclin D1IBA
06/2014 - 05/2002
12Phosphotransferases (Kinase)IBA
12/2014 - 08/2004
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 06/2008
11Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
04/2013 - 04/2002
10tranilast (N 5')IBA
06/2015 - 02/2002
10nucleophosminIBA
12/2013 - 09/2003
10Messenger RNA (mRNA)IBA
08/2012 - 05/2002
9Vincristine (Oncovin)FDA LinkGeneric
11/2015 - 03/2002
8Methotrexate (Mexate)FDA LinkGeneric
11/2015 - 10/2005
8DNA (Deoxyribonucleic Acid)IBA
11/2015 - 08/2002
8RNA (Ribonucleic Acid)IBA
09/2015 - 04/2004
8ParaffinIBA
08/2014 - 02/2002
8AntigensIBA
08/2014 - 02/2002
7T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2015 - 02/2002
7AntibodiesIBA
04/2015 - 04/2004
7Pyridinolcarbamate (P23)IBA
11/2014 - 05/2002
6Cytarabine (Cytosar-U)FDA LinkGeneric
11/2015 - 10/2005
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015 - 04/2010
6Prednisone (Sone)FDA LinkGeneric
10/2015 - 03/2002
6Biological Markers (Surrogate Marker)IBA
03/2015 - 11/2010
6Formaldehyde (Formol)FDA Link
08/2014 - 09/2003
5MicroRNAs (MicroRNA)IBA
06/2015 - 07/2011
5Peroxidase (Myeloperoxidase)IBA
08/2014 - 08/2005
5RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2013 - 03/2007
5imatinib (Gleevec)FDA Link
12/2012 - 07/2004
5fludarabineIBA
06/2012 - 02/2002
5Immunoglobulin M (IgM)IBA
03/2011 - 08/2003
5Sirolimus (Rapamycin)FDA Link
12/2010 - 07/2006
5NF-kappa B (NF-kB)IBA
09/2007 - 02/2004
4Dexamethasone (Maxidex)FDA LinkGeneric
11/2015 - 02/2002
4Immunoglobulins (Immunoglobulin)IBA
08/2015 - 01/2011
4Muramidase (Lysozyme)IBA
08/2014 - 08/2005
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2013 - 01/2011
4monosomy Chromosome 7IBA
03/2011 - 04/2006
4Caspase 3 (Caspase-3)IBA
03/2009 - 01/2004
4Vinblastine (Vinblastine Sulfate)FDA Link
11/2006 - 03/2002
4Dacarbazine (DIC)FDA LinkGeneric
11/2006 - 03/2002
4Bleomycin (Blenoxane)FDA LinkGeneric
11/2006 - 03/2002
3Granzymes (Granzyme)IBA
11/2015 - 11/2012
3Inhibitor of Apoptosis ProteinsIBA
10/2015 - 10/2006
3Reticulin (Reticular Fiber)IBA
10/2015 - 07/2004
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2015 - 02/2009
3Tyrosine (L-Tyrosine)FDA Link
12/2014 - 09/2003
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2014 - 07/2004
3DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
08/2014 - 05/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013 - 01/2006
3aurora kinase (aurora A kinase)IBA
05/2013 - 12/2008
3Transcription Factors (Transcription Factor)IBA
09/2012 - 06/2005
317-(allylamino)-17-demethoxygeldanamycin (17AAG)IBA
05/2012 - 01/2006
3B-Cell-Specific Activator ProteinIBA
02/2012 - 04/2004
3Adenosine Triphosphate (ATP)IBA
01/2012 - 10/2009
3CreatinineIBA
10/2011 - 10/2007

Therapy/Procedure

33Drug Therapy (Chemotherapy)
08/2015 - 02/2002
9Stem Cell Transplantation
05/2015 - 10/2006
7Breast Implants (Breast Implant)
10/2015 - 09/2009
5Transplants (Transplant)
05/2014 - 08/2005
4Transplantation (Transplant Recipients)
11/2015 - 02/2005
4Radiotherapy
07/2014 - 03/2002
4Lasers (Laser)
04/2014 - 09/2003
4Investigational Therapies (Experimental Therapy)
10/2005 - 08/2004
3Aftercare (After-Treatment)
05/2013 - 01/2004
3Splenectomy
11/2012 - 04/2006